These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29544641)

  • 21. Cell death in response to antimetabolites directed at thymidylate synthase.
    Barbour KW; Berger FG
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):189-201. PubMed ID: 17396263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downstream molecular determinants of response to 5-fluorouracil and antifolate thymidylate synthase inhibitors.
    Van Triest B; Pinedo HM; Giaccone G; Peters GJ
    Ann Oncol; 2000 Apr; 11(4):385-91. PubMed ID: 10847455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitor specificity via protein dynamics: insights from the design of antibacterial agents targeted against thymidylate synthase.
    Ferrari S; Costi PM; Wade RC
    Chem Biol; 2003 Dec; 10(12):1183-93. PubMed ID: 14700626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thymidylate synthase inhibitors as anticancer agents: from bench to bedside.
    Chu E; Callender MA; Farrell MP; Schmitz JC
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S80-9. PubMed ID: 12819937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The means to an end of tumor cell resistance to chemotherapeutic drugs targeting thymidylate synthase: shoot the messenger.
    Berg RW; Ferguso PJ; DeMoor JM; Vincen MD; Koropatnick J
    Curr Drug Targets; 2002 Aug; 3(4):297-309. PubMed ID: 12102601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Future potential of thymidylate synthase inhibitors in cancer therapy.
    Lehman NL
    Expert Opin Investig Drugs; 2002 Dec; 11(12):1775-87. PubMed ID: 12457437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural aspects of the inhibition and catalytic mechanism of thymidylate synthase.
    Hardy LW
    Acta Biochim Pol; 1995; 42(4):367-80. PubMed ID: 8852328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular quantitative detection of human thymidylate synthase engagement with an unconventional inhibitor using tetracysteine-diarsenical-probe technology.
    Ponterini G; Martello A; Pavesi G; Lauriola A; Luciani R; Santucci M; Pelà M; Gozzi G; Pacifico S; Guerrini R; Marverti G; Costi MP; D'Arca D
    Sci Rep; 2016 Jun; 6():27198. PubMed ID: 27250901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, characterization and molecular docking studies of thiouracil derivatives as potent thymidylate synthase inhibitors and potential anticancer agents.
    El-Naggar AM; Abou-El-Regal MM; El-Metwally SA; Sherbiny FF; Eissa IH
    Mol Divers; 2017 Nov; 21(4):967-983. PubMed ID: 28815411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thymidylate synthase inhibitors.
    Touroutoglou N; Pazdur R
    Clin Cancer Res; 1996 Feb; 2(2):227-43. PubMed ID: 9816165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth.
    Costantino L; Ferrari S; Santucci M; Salo-Ahen OMH; Carosati E; Franchini S; Lauriola A; Pozzi C; Trande M; Gozzi G; Saxena P; Cannazza G; Losi L; Cardinale D; Venturelli A; Quotadamo A; Linciano P; Tagliazucchi L; Moschella MG; Guerrini R; Pacifico S; Luciani R; Genovese F; Henrich S; Alboni S; Santarem N; da Silva Cordeiro A; Giovannetti E; Peters GJ; Pinton P; Rimessi A; Cruciani G; Stroud RM; Wade RC; Mangani S; Marverti G; D'Arca D; Ponterini G; Costi MP
    Elife; 2022 Dec; 11():. PubMed ID: 36475542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Targets of Active Anticancer Compounds Derived from Marine Sources.
    Song X; Xiong Y; Qi X; Tang W; Dai J; Gu Q; Li J
    Mar Drugs; 2018 May; 16(5):. PubMed ID: 29786660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An insight into thymidylate synthase inhibitor as anticancer agents: an explicative review.
    Sen A; Karati D
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug; 397(8):5437-5448. PubMed ID: 38446215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-based design of lipophilic quinazoline inhibitors of thymidylate synthase.
    Jones TR; Varney MD; Webber SE; Lewis KK; Marzoni GP; Palmer CL; Kathardekar V; Welsh KM; Webber S; Matthews DA; Appelt K; Smith WW; Janson CA; Villafranca JE; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Moomaw EW; Bartlett CA; Morse CA
    J Med Chem; 1996 Feb; 39(4):904-17. PubMed ID: 8632414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The crystal structure of thymidylate synthase from Pneumocystis carinii reveals a fungal insert important for drug design.
    Anderson AC; Perry KM; Freymann DM; Stroud RM
    J Mol Biol; 2000 Mar; 297(3):645-57. PubMed ID: 10731418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymidylate synthase expression in advanced colorectal cancer predicts for response to raltitrexed.
    Farrugia DC; Ford HE; Cunningham D; Danenberg KD; Danenberg PV; Brabender J; McVicar AD; Aherne GW; Hardcastle A; McCarthy K; Jackman AL
    Clin Cancer Res; 2003 Feb; 9(2):792-801. PubMed ID: 12576452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tomudex (ZD1694, NSC 639186) in platinum-pretreated recurrent epithelial ovarian cancer: a phase II study by the Gynecologic Oncology Group.
    Muggia FM; Blessing JA; Homesley HD; Sorosky J
    Cancer Chemother Pharmacol; 1998; 42(1):68-70. PubMed ID: 9619760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-based studies on species-specific inhibition of thymidylate synthase.
    Costi MP; Tondi D; Rinaldi M; Barlocco D; Pecorari P; Soragni F; Venturelli A; Stroud RM
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):206-14. PubMed ID: 12084462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New anticancer agents in clinical development.
    Eckardt J; Eckhardt G; Villalona-Calero M; Drengler R; Von Hoff D
    Oncology (Williston Park); 1995 Dec; 9(12):1321-8; 1331; discussion 1332-4. PubMed ID: 8771106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure of human thymidylate synthase suggests advantages of chemotherapy with noncompetitive inhibitors.
    Phan J; Steadman DJ; Koli S; Ding WC; Minor W; Dunlap RB; Berger SH; Lebioda L
    J Biol Chem; 2001 Apr; 276(17):14170-7. PubMed ID: 11278511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.